CS274992B2 - Method of porcine insulin's analogue preparation - Google Patents

Method of porcine insulin's analogue preparation

Info

Publication number
CS274992B2
CS274992B2 CS245289A CS245289A CS274992B2 CS 274992 B2 CS274992 B2 CS 274992B2 CS 245289 A CS245289 A CS 245289A CS 245289 A CS245289 A CS 245289A CS 274992 B2 CS274992 B2 CS 274992B2
Authority
CS
Czechoslovakia
Prior art keywords
porcine insulin
insulin
prototype
analogue preparation
porcine
Prior art date
Application number
CS245289A
Other languages
Czech (cs)
Other versions
CS8902452A1 (en
Inventor
Ivan Rndr Svoboda
Jana Rndr Csc Barthova
Jan Ing Csc Pospisek
Tomas Ing Buchvaldek
Milena Rndr Braunsteinova
Alena Hankeova
Tomislav Rndr Csc Barth
Original Assignee
Ustav Organicke Chemie A Bioch
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ustav Organicke Chemie A Bioch filed Critical Ustav Organicke Chemie A Bioch
Priority to CS245289A priority Critical patent/CS274992B2/en
Publication of CS8902452A1 publication Critical patent/CS8902452A1/en
Publication of CS274992B2 publication Critical patent/CS274992B2/en

Links

Landscapes

  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The invention solves the production of the prototype of porcine insulin by the condensation reaction of amino acid component and des-Ala <B30> insulin with the initial content of zinc during catalysis by trypsin. The reaction takes place in the medium of 60 percent by volume of hydrous dimethylformamide with pH between 6 and 8, at the temperature between 18 and 20 degrees C for the duration between 10 and 20 hours. The prototype of porcine insulin is fully biologically active and can be used in pharmaceutical industry, especially for treatment of diabetes.
CS245289A 1989-04-20 1989-04-20 Method of porcine insulin's analogue preparation CS274992B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CS245289A CS274992B2 (en) 1989-04-20 1989-04-20 Method of porcine insulin's analogue preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CS245289A CS274992B2 (en) 1989-04-20 1989-04-20 Method of porcine insulin's analogue preparation

Publications (2)

Publication Number Publication Date
CS8902452A1 CS8902452A1 (en) 1991-02-12
CS274992B2 true CS274992B2 (en) 1991-12-17

Family

ID=5361715

Family Applications (1)

Application Number Title Priority Date Filing Date
CS245289A CS274992B2 (en) 1989-04-20 1989-04-20 Method of porcine insulin's analogue preparation

Country Status (1)

Country Link
CS (1) CS274992B2 (en)

Also Published As

Publication number Publication date
CS8902452A1 (en) 1991-02-12

Similar Documents

Publication Publication Date Title
HUT47977A (en) Polipeptides, process for their production and process for production of medical compositions containing such active substances
UA27874C2 (en) HUMAN INSULIN DRUG, METHOD OF PREPARATION OF THE DRUG, METHOD OF TREATMENT OF DIABETES MELLITUS
CA2105502A1 (en) Insulin Secretion Stimulating Composition for the Treatment of Non-Insulin-Dependent Diabetes
YU141088A (en) Process for obtaining piperazinyl derivatives of purines and their izostereomers
ES8106407A1 (en) Aqueous solutions of proteins stable against denaturization, process for their manufacture, and their utilization.
AU2026895A (en) Glucagon-like insulinotropic complexes, compositions and methods
PL346520A1 (en) Novel heteroaromatic inhibitors of fructose 1,6-bisphosphatase
EP0401199A3 (en) Method for the preparation of biological implant material
EP1338651A4 (en) Method of screening remedy for diabetes
ATE383424T1 (en) POLYPEPTIDES, THEIR PRODUCTION AND USE
DE69020335D1 (en) B-CHAIN ANALOGS OF THE GROWTH FACTOR DERIVED FROM BLOOD PLATES AND METHOD FOR THEIR HOMOGENOUS PRODUCTION.
HUT50443A (en) Process for producing pharmaceutical composition suitable for treating diabetes mellitus
KR860002268A (en) Method for preparing skin nutrient
ATE95522T1 (en) PROCESS FOR THE PREPARATION OF DES-B30 INSULINES AND DES-B30 INSULIN DERIVATIVES.
Brange et al. Chemical stability of insulin. 5. Isolation, characterization and identification of insulin transformation products
GB2176489A (en) Polypeptide and polypeptide composition
ZA883599B (en) Mixed crystals of insulin and insulin derivatives,a process for the preparation of these mixed crystals,pharmaceutical agents containing these mixed crystals,and the use thereof for the treatment of diabetes mellitus
CS274992B2 (en) Method of porcine insulin&#39;s analogue preparation
EP0336779A3 (en) Polypeptides stabilized by covalent hydrogen bond replacements
WO1988007580A3 (en) Biophysically derived ascomycetes, schizomycetes and yeast preparation, process for the manufacture thereof and fodder and plant hormones containing this preparation, and use of the preparations for skin treatment and probiotic activation
AU3744889A (en) Variants of plasminogen activators and processes for their production
KR900005994A (en) Pharmaceutical preparations for the treatment of diseases caused by thrombocytopenia or thrombocytopenia
EP0370994A3 (en) Treatment of glucose-intermediated cross-linking of collagen in patients with diabetes mellitus by arginin, spermidin, creatin or agmatin
WO1996005845A3 (en) Treatment of disease and conditions associated with macrophage infiltration in particular stroke and myocardial infarction
AU7508694A (en) Novel tyrosine kinase